Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Hepatoblastoma imaging with gadoxetate disodium-enhanced MRI--typical, atypical, pre- and post-treatment evaluation.

Autor: Meyers AB, Towbin AJ, Geller JI, Podberesky DJ, Meyers, Arthur B, Towbin, Alexander J, Geller, James I, Podberesky, Daniel J

Publikováno v: Pediatric Radiology; Jul2012, Vol. 42 Issue 7, p859-866, 8p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Long-term outcomes and patterns of relapse in patients with bilateral Wilms tumor or bilaterally predisposed unilateral Wilms tumor, a report from the COG AREN0534 study.

Autor: Murphy AJ; St Jude Children's Research Hospital, Memphis, Tennessee, USA., Brzezinski J; Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Renfro LA; Division of Biostatistics, University of Southern California and Children's Oncology Group, Los Angeles, California, USA., Tornwall B; Division of Biostatistics, University of Southern California and Children's Oncology Group, Los Angeles, California, USA.; Glaukos Corp., San Clemente, California, USA., Malek MM; Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Benedetti DJ; Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Cost NG; The Surgical Oncology Program at the Children's Hospital of Colorado, University of Colorado, Denver, Colorado, USA., Smith EA; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Aldrink J; Division of Pediatric Surgery, Department of Surgery, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, Ohio, USA., Romao RLP; Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Dome JS; Children National Hospital, George Washington University School of Medicine and Health Sciences, Washington, DC, USA., Davidoff AM; St Jude Children's Research Hospital, Memphis, Tennessee, USA., Treece AL; Ann & Robert H. Lurie Children's Hospital, Chicago, Illinois, USA., Parsons LN; Department of Pathology, Children's Hospital of Wisconsin, Milwaukee, Wisconsin, USA., Mullen EA; Boston Children's Hospital and Dana Farber Cancer Institute, Boston, Massachusetts, USA., Shamberger RC; Boston Children's Hospital and Dana Farber Cancer Institute, Boston, Massachusetts, USA., Paulino AC; MD Anderson Cancer Center, Houston, Texas, USA., Lo AC; University of British Columbia, Vancouver, British Columbia, Canada., Geller JI; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Ehrlich PF; Section of Pediatric Surgery, CS Mott Children's Hospital, University of Michigan, Ann Arbor, Michigan, USA.

Publikováno v: International journal of cancer [Int J Cancer] 2024 Nov 15; Vol. 155 (10), pp. 1824-1831. Date of Electronic Publication: 2024 Jul 08.

Outcome after treatment with axitinib in children, young adults, and adults with renal cell carcinoma: a narrative review.

Autor: Sprokkerieft J; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: j.sprokkerieft@prinsesmaximacentrum.nl., van der Beek JN; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Spreafico F; Pediatric Oncology Unit, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Selle B; Hopp Children's Cancer Center Heidelberg (KiTZ) & Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany., Chowdhury T; Pediatric Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom., Graf N; Department of Pediatric Oncology and Hematology, Saarland University, Homburg, Germany., Verschuur AC; Department of Pediatric Hematology-Oncology, Hôpital d'Enfants de la Timone, APHM, Marseille, France., Dandis R; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Bex A; Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam 1066CX, the Netherlands; Division of Surgical and Interventional Science, The Royal Free London NHS Foundation Trust and UCL, London, UK., Geller JI; Division of Oncology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, USA., Tytgat GAM; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van den Heuvel-Eibrink MM; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

Publikováno v: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2024 Sep 24; Vol. 204, pp. 104523. Date of Electronic Publication: 2024 Sep 24.